The survival difference for tumors with different scores is most striking for high-stage neuroblastoma tumors without MYCN amplification, while all tumors with MYCN amplification have higher ESC miRNA signature scores compared to non-amplified tumors. Here, MYCN is linked to neuroblastoma.